FDA Inspection
Tris Pharma Inc.Tris Pharma Inc. – FDA Inspection, Jun 8, 2021
Record Details
This FDA Inspection record concerns Tris Pharma Inc., with an inspection on June 8, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Tris Pharma Inc.
- Inspection Date
- June 8, 2021
- Product Type
- Drugs
View Company Profile
ID · 0d3df2aa-17b0-4cd8-b8b1-3c73c074e44d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1143403
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 314.81(b)(1)(ii)Failure to meet specifications
- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.192Extent of discrepancy, failure investigations
- 21 CFR 211.28(a)Protective Apparel Not Worn
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tris Pharma Inc.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
| March 8, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 23, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 16, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 20, 2017 | OAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Tris Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.